PlainRecalls

Sato Pharmaceutical Inc.

Compiled from official public sources by the publisher.

9 recalls on record · Latest: Jun 10, 2026

Subscribe to new Sato Pharmaceutical Inc. recalls (RSS)

Agency notice ledger

Federal filing book Sato Pharmaceutical Inc. LIGHT-BOOK · MULTI-AGENCY

#1,657 of 14,151 · 9 notices · 0.009% archive

  • BOOK 9 notices
  • RANK #1,657 of 14,151
  • SHARE 0.009% archive
  • AGENCY FDA Drug (8)
  • CAT drugs
  • CATS 2 categories
  • LATEST Jun 10, 2026
  • PHOTO 3Cs Organics LLC

Nearest notice-volume peer: 3Cs Organics LLC (0 notice gap)

Sato Pharmaceutical Inc. accounts for about 0.009% of the 104,423-notice archive on 9 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Sato Pharmaceutical Inc. compares to 14,151 recalling firms

Sato Pharmaceutical Inc. ranks 1,657th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Sato Pharmaceutical Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

9 1657th of 14151 higher than 12,464 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Sato Pharmaceutical Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Sato Pharmaceutical Inc. holds about 0.009% of archive notices alongside 9 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026

How the 9 notices break down

Same federal filing book as the hero total — split by issuing agency, no new counts.

FDA Food Low Jun 10, 2026

Yunker(branded) Energy & Health Herbal Supplement with Vitamins; Manufactured by Sato Pharmaceuticals Co. Ltd.; 30ml container. Packed in single serving, 3 units/pack, and 10 units per pack. Single UPC: 49873-916-11 3pack UPC: 49873-916-15 10pack UPC: 49873-916-07
FDA Drug Low Nov 20, 2019

Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 59779-534-01. UPC 050428345535
FDA Drug Low Nov 20, 2019

Motion Sickness Strips (meclizine hydrochloride) 25 mg strips, 8-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 69842-288-01. UPC 5042849946
FDA Drug Low Nov 20, 2019

WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and b) 18-count boxes (NDC 0363-1407-02, UPC 3 11917-20318 8) Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501,
FDA Drug Low Nov 20, 2019

Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 49873-803-01. UPC 4987301603
FDA Drug Low Nov 13, 2019

Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by SATO PHARMACEUTICAL CO., LTD., 1-5-27 Motoakasaka Minato-KU Tokyo, Japan; SATO PHARMACEUTICAL, INC., 20695 S. Western Ave., Suite 240, Torrance, CA 90501; NDC 49873-404-01.
FDA Drug Moderate May 31, 2017

Optic Splash (naphazoline hydrochloride) Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-501-01.
FDA Drug Moderate May 31, 2017

DORAMA-NEO (naphazoline hydrochloride) Eye wash, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-020-01
FDA Drug Moderate May 31, 2017

SATO CLEAR (naphazoline hydrochloride) Redness Reliever Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-044-01

Sato Pharmaceutical Inc. holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (9 here).

3Cs Organics LLC 9 4 C Foods, Corp. 9 A New Life Herbs, LLC 9 A-s Medication Solutions LLC 9 Abbott Nutrition 9

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

A New Life Herbs, LLC 9 A-s Medication Solutions LLC 9 Dermamedics, L.L.C. 9 GlaxoSmithkline Consmer Healthcare 9

Frequently Asked Questions

How many federal recall notices name Sato Pharmaceutical Inc.? ▼
PlainRecalls indexes 9 distinct federal recall events naming Sato Pharmaceutical Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Sato Pharmaceutical Inc. sit among other recalling firms? ▼
Sato Pharmaceutical Inc. ranks #1,657 of 14,151 by distinct recall-event count among 14,151 firms in this archive (88th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Sato Pharmaceutical Inc.'s notices? ▼
FDA Drug accounts for 8 of this firm's 9 indexed notices across 2 issuing agencies.
What product category dominates Sato Pharmaceutical Inc.'s filing book? ▼
Filings for Sato Pharmaceutical Inc. span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Sato Pharmaceutical Inc.: 9 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Sato Pharmaceutical Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026